IP Verse

Amgen Switzerland Ag Vilniaus Filialas vs. Alexion Pharmaceuticals - ACT_59173/2024

Explore detailed information on the case number ACT_59173/2024 involving Amgen Switzerland Ag Vilniaus Filialas and Alexion Pharmaceuticals which was filed on 31 Oct, 2024.

Case Details

    Case Number:

    ACT_59173/2024

    Patent Number:

    EP3167888

    Filing Date:

    31 Oct, 2024

    Proceeding Type:

    Proceeding

    Action/Application:

    Revocation Action

    Plaintiffs:

    • Amgen Switzerland Ag Vilniaus Filialas Represented By Axel Berger

    Defendants:

    • Alexion Pharmaceuticals, Inc. Represented By Elena Hennecke

    Judges:

    • Marije Knijff
    • Rudi Goedeweeck
    • andrea postiglione

    Court Division:

    First Instance, Central Division - Milan

Case Decision

Decision pending - set alert to receive updates

More cases on EP3167888B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 7, 2025
Case NumberPlaintiffsDefendants
ACT_13849/2024Alexion PharmaceuticalsSamsung Bioepis Nl B.V.
ACT_13886/2024Alexion PharmaceuticalsAmgen N.V., Amgen Biofarmaceutica Lda., Amgen Gmbh, Amgen S.A.S., Amgen Zdravila D.O.O., Amgen Technology (Ireland) Unlimited Company, Amgen Ab, Amgen S.R.L.
APL_40470/2024Alexion PharmaceuticalsSamsung Bioepis Nl B.V.
APL_40553/2024Alexion PharmaceuticalsAmgen Technology (Ireland) Unlimited Company, Amgen N.V., Amgen Gmbh, Amgen Ab, Amgen S.A.S., Amgen S.R.L., Amgen Biofarmaceutica Lda., Amgen Zdravila D.O.O.

More cases on Amgen Switzerland Ag Vilniaus Filialas

No cases found - set alert to stay updated on new cases

More cases on Alexion Pharmaceuticals

No cases found - set alert to stay updated on new cases